$OVID 4 SEC Filings

Filed On	Filing
08 Jul 2026	Form 4: Carter Charles Ross, Chief Financial Officer Received 50,000 shares as a grant or award
17 Jun 2026	Form 4: Greka Anna, Director Granted 130,000 Stock Option (right to buy)
09 Apr 2026	Form 4: Papadopoulos Stelios, Director Received 17,578 shares as a grant or award ($45K)
09 Apr 2026	Form 4: Friedman Bart, Director Received 8,789 shares as a grant or award ($22.5K)
09 Apr 2026	Form 4: Fitzgerald Kevin Joseph, Director Received 17,578 shares as a grant or award ($45K)
25 Mar 2026	Form 4: Levin Jeremy M, Director Received 47,333 shares by exercise or conversion ($66.3K)
02 Mar 2026	Form 4: Alexander Margaret A., Director Sold 11,656 shares ($16.9K) · Granted 1,435,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Papadopoulos Stelios, Director Granted 65,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Fitzgerald Kevin Joseph, Director Granted 65,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Levin Jeremy M, Director Granted 957,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Friedman Bart, Director Granted 65,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Duncan Barbara Gayle, Director Granted 65,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Bernstein Karen, Director Granted 65,000 Employee Stock Option (Right to Buy)
02 Mar 2026	Form 4: Rona Jeffrey A, CBFO Sold 8,541 shares ($12.4K) · Received 68,125 shares as a grant or award · Granted 408,750 Employee Stock Option (Right to Buy)
05 Jan 2026	Form 4: Alexander Margaret A., Director Granted 890,000 Employee Stock Option (right to buy)
18 Dec 2025	Form 4: Levin Jeremy M, Director Acquired 71 Series B Convertible Preferred Stock (Open Market Purchase) · Acquired 47,333 Series A Warrant (right to buy) (Open Market Purchase) · Acquired 35,500 Series B Warrant (right to buy) (Open Market Purchase) · 1 more
09 Dec 2025	Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other Received 1,250,000 shares by conversion
18 Jun 2025	Form 4: Fitzgerald Kevin Joseph, Director Granted 45,000 Stock Option (right to buy)
18 Jun 2025	Form 4: Friedman Bart, Director Granted 45,000 Stock Option (right to buy)
18 Jun 2025	Form 4: Duncan Barbara Gayle, Director Granted 45,000 Stock Option (right to buy)

Comments